tetano
Editor, Senior Moderator
Cureus
. 2024 Jun 3;16(6):e61614.
doi: 10.7759/cureus.61614. eCollection 2024 Jun. Two Cases of Lung Abscess and Pleuritis in Severe COVID-19 Patients
Shiho Goda[SUP] 1 [/SUP], Tatsuya Yuba[SUP] 2 [/SUP], Kohei Yamamoto[SUP] 1 [/SUP], Misaki Sasakura[SUP] 1 [/SUP], Noriya Hiraoka[SUP] 1 [/SUP]
Affiliations
We report two patients who were treated with remdesivir, steroids, and tocilizumab for severe coronavirus disease 2019 (COVID-19) and developed lung abscesses and pleuritis. Although complications due to bacterial infections are often reported in COVID-19 patients, these severe infections are rare. Patients receiving tocilizumab are at a high risk of developing serious bacterial infections, and the diagnosis is often delayed because symptoms such as fever and elevated C-reactive protein levels are often minimal. The possibility of complications owing to severe bacterial infections should be considered when treating patients with severe COVID-19.
Keywords: covid-19; lung abscess; pleuritis; secondary bacterial infection; tocilizumab.
. 2024 Jun 3;16(6):e61614.
doi: 10.7759/cureus.61614. eCollection 2024 Jun. Two Cases of Lung Abscess and Pleuritis in Severe COVID-19 Patients
Shiho Goda[SUP] 1 [/SUP], Tatsuya Yuba[SUP] 2 [/SUP], Kohei Yamamoto[SUP] 1 [/SUP], Misaki Sasakura[SUP] 1 [/SUP], Noriya Hiraoka[SUP] 1 [/SUP]
Affiliations
- PMID: 38962614
- PMCID: PMC11221974
- DOI: 10.7759/cureus.61614
We report two patients who were treated with remdesivir, steroids, and tocilizumab for severe coronavirus disease 2019 (COVID-19) and developed lung abscesses and pleuritis. Although complications due to bacterial infections are often reported in COVID-19 patients, these severe infections are rare. Patients receiving tocilizumab are at a high risk of developing serious bacterial infections, and the diagnosis is often delayed because symptoms such as fever and elevated C-reactive protein levels are often minimal. The possibility of complications owing to severe bacterial infections should be considered when treating patients with severe COVID-19.
Keywords: covid-19; lung abscess; pleuritis; secondary bacterial infection; tocilizumab.